Rachel Black
Adelaide Medical School
Faculty of Health and Medical Sciences
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Rachel is a rheumatologist and clinician researcher who completed her PhD in 2019 looking at the epidemiology and patient perspectives of glucocorticoid use and adverse effects in rheumatoid arthritis and other inflammatory diseases. Her interests include pharmacoepidemiology and the use of big data to answer research questions directly relevant to her clinical practice in rheumatology.
Current Projects
A Randomised Clinical Trial of a Glucocorticoid Tapering Intervention for Rheumatoid Arthritis Patients- Recruitment complete.
Reassessing The Mortality Gap in Rheumatoid Arthritis in Australia- A data linkage project.
OMERACT Glucocorticoid Working Group- Systematic literature review looking at validated instruments for measuring glucocorticoid outcomes in clinical trials.
Epidemiology of Rheumatic Diseases in Australia- A collaborative data linkage project.
Optimising transition care for adolescents with juvenile rheumatic disease in South Australia- A collaborative multi-methods service improvement project.
-
Appointments
Date Position Institution name 2018 - ongoing Consultant Rheumatologist The Queen Elizabeth Hospital 2016 - ongoing Clinical Lecturer University of Adelaide 2015 - ongoing Consultant Rheumatologist Royal Adelaide Hospital -
Awards and Achievements
Date Type Title Institution Name Country Amount 2015 Scholarship Arthritis SA/Australian Rheumatology Association (SA) Postgraduate Grant - - - 2014 Scholarship Australian Postgraduate Award (The University of Adelaide) The University of Adelaide Australia - 2013 Fellowship Ken Muirden Overseas Training Fellowship Arthritis Research UK Centre for Epidemiology, The University of Manchester United Kingdom - -
Education
Date Institution name Country Title 2013 - 2019 University of Adelaide Australia PhD 1999 - 2004 University of Adelaide Australia MBBS -
Postgraduate Training
Date Title Institution Country 2007 - 2012 FRACP Royal Australasian College of Physicians Australia -
Research Interests
-
Journals
Year Citation 2025 Russell, O., Lester, S., Black, R. J., Lassere, M., Barrett, C., March, L., . . . Hill, C. L. (2025). Area-Level Socioeconomic Status Impacts Health Care Visit Frequency by Australian Patients With Inflammatory Arthritis: Results From the Australian Rheumatology Association Database. Arthritis Care and Research, 77(1), 127-135.
2025 Tieu, J., Cheah, J. T., Lyne, S., Yip, K., Ghosh, N., Richards, P., . . . Goodman, S. M. (2025). Prioritising domains of glucocorticoid therapy to measure in trials: Results from a modified delphi exercise from the OMERACT glucocorticoid impact working group. Seminars in Arthritis and Rheumatism, 71, 6 pages.
2025 Bryant, M. J., Black, R. J., & Hill, C. L. (2025). Measuring Patient Experience in Rheumatology Outpatient Care. International Journal of Rheumatic Diseases, 28(1), 3 pages.
2025 Lyon, A., Lester, S., Stanhope, J., Lynch, T., Black, R., Barrett, C., . . . Hill, C. (2025). Dual-energy X-ray absorptiometry and anti-osteoporotic medication use in Australian patients with early rheumatoid arthritis using data from the Australian Rheumatology Association Database. Internal Medicine Journal, 9 pages.
2025 Bryant, M. J., Lester, S., Russell, O., Whittle, S., Limaye, V., Proudman, S., . . . Hill, C. L. (2025). Implementation of a novel patient reported experience measure (PREM) in rheumatology: a cross-sectional online survey of Australian rheumatology outpatients. Rheumatology International, 45(6), 10 pages.
2024 Lyne, S. A., Yip, K., Vasiliou, V. S., Katz, D. A., Richards, P., Tieu, J., . . . Hill, C. L. (2024). Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases. Seminars in Arthritis and Rheumatism, 64, 7 pages.
Scopus12024 Pisaniello, H. L., Lester, S. E., Russell, O., Black, R., Tieu, J., Richards, B., . . . Whittle, S. L. (2024). The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD). Annals of the Rheumatic Diseases, 83(10), 1400-1402.
2024 Bryant, M. J., Black, R. J., Lester, S., Chand, V., Barrett, C., Buchbinder, R., . . . Hill, C. L. (2024). Australian adaptation and external validation of Commissioning for Quality in Rheumatoid Arthritis-RA-Patient Reported Experience Measure (CQRA-RA-PREM). Rheumatology Advances in Practice, 8(4), 9 pages.
Scopus1 Europe PMC22023 Pisaniello, H. L., Lester, S., Russell, O., Black, R., Tieu, J., Richards, B., . . . Hill, C. L. (2023). Trajectories of self-reported pain-related health outcomes and longitudinal effects on medication use in rheumatoid arthritis: a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD). RMD Open, 9(3), e002962.
Scopus6 Europe PMC32023 Black, R. J., Cross, M., Haile, L. M., Culbreth, G., Steinmetz, J., Hagins, H., . . . March., L. M. (2023). Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. LANCET RHEUMATOLOGY, 5(10), E594-E610.
Scopus195 WoS82023 Bridgewater, S., Shepherd, M. A., Dawson, J., Richards, P., Silverthorne, C., Ndosi, M., . . . Robson, J. C. (2023). Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: International development of a glucocorticoid treatment-specific patient-reported outcome measure. Rheumatology (United Kingdom), 62(11), 3565-3575.
Scopus4 WoS2 Europe PMC42023 Black, R. J., Lester, S., Tieu, J., Sinnathurai, P., Barrett, C., Buchbinder, R., . . . Hill, C. L. (2023). Mortality estimates and excess mortality in rheumatoid arthritis. Rheumatology, 62(11), 3576-3583.
Scopus23 WoS4 Europe PMC172023 Lyon, A., Quinlivan, A., Lester, S., Barrett, C., Whittle, S. L., Rowett, D., . . . Hill, C. L. (2023). Vaccination Rates, Perceptions, and Information Sources Used by People With Inflammatory Arthritis. ACR Open Rheumatology, 5(2), 1-9.
Scopus5 WoS2 Europe PMC32023 Russell, O., Lester, S., Black, R. J., & Hill, C. L. (2023). Socioeconomic Status and Medication Use in Rheumatoid Arthritis: A Scoping Review. Arthritis Care and Research, 75(1), 92-100.
Scopus9 WoS1 Europe PMC42022 McMaster, C., Liew, D. F. L., Lester, S., Rischin, A., Black, R. J., Chand, V., . . . Hill, C. L. (2022). COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohort. Rheumatology, 62(4), 1-7.
Scopus3 WoS3 Europe PMC22022 Ruediger, C., Ninan, J., Dyer, K., Lyne, S., Tieu, J., Black, R. J., . . . Hill, C. L. (2022). Diagnosis of giant cell arteritis by temporal artery biopsy is associated with biopsy length. Frontiers in Medicine, 9, 6 pages.
Scopus3 Europe PMC32022 Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Rowett, D., Black, R., . . . Hill, C. (2022). Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilars. Rheumatology Advances in Practice, 6(3), rkac099-1-rkac099-7.
Scopus5 WoS1 Europe PMC42021 Tieu, J., Cheah, J. T., Black, R. J., Christensen, R., Ghosh, N., Richards, P., . . . Hill, C. L. (2021). Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set. Seminars in Arthritis and Rheumatism, 51(5), 1139-1145.
Scopus12 WoS1 Europe PMC42021 Rischin, A., Liew, D., Black, R., Fletcher, A., Buchbinder, R., Lassere, M., . . . Hill, C. (2021). Healthcare access and attitudes towards telehealth during the early phase of the COVID ‐19 pandemic among an Australian cohort with inflammatory arthritis. Internal Medicine Journal, 51(5), 788-792.
Scopus4 WoS3 Europe PMC32021 Venter, G., Tieu, J., Black, R., Lester, S., Leonardo, N., Whittle, S. L., . . . Hill, C. L. (2021). PERSPECTIVES OF GLUCOCORTICOID USE IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS. ACR Open Rheumatology, 3(4), 231-238.
Scopus13 WoS7 Europe PMC92021 Bryant, M. J., Schubert, J. P., Black, R. J., & Hill, C. L. (2021). Patient-Reported Experience Measures in outpatient rheumatology care: A systematic review. Rheumatology Advances in Practice, 5(3), 10 pages.
Scopus6 Europe PMC42020 Cheah, J. T., Robson, J. C., Black, R. J., Goodman, S. M., Lester, S., Mackie, S. L., & Hill, C. L. (2020). The patient's perspective of the adverse effects of glucocorticoid use: A systematic review of quantitative and qualitative studies. From an OMERACT working group. Seminars in Arthritis and Rheumatism, 50(5), 996-1005.
Scopus23 WoS11 Europe PMC152020 Ruediger, C., Nguyen, L., Black, R., Proudman, S., & Hill, C. (2020). Efficacy of Methotrexate in Polymyalgia Rheumatica in routine rheumatology clinical care.. Internal medicine journal, 50(9), 1067-1072.
Scopus7 WoS1 Europe PMC32019 Cheah, J. T. L., Black, R. J., Robson, J. C., Navarro-Millán, I. Y., Young, S. R., Richards, P., . . . Hill, C. L. (2019). Toward a core domain set for glucocorticoid impact in inflammatory rheumatic diseases: The OMERACT 2018 glucocorticoid impact working group. Journal of Rheumatology, 46(9), 1179-1182.
Scopus9 WoS8 Europe PMC52019 Black, R. J., Richards, B., Lester, S., Buchbinder, R., Barrett, C., Lassere, M., . . . Hill, C. L. (2019). Factors associated with commencing and ceasing opioid therapy in patients with rheumatoid arthritis. Seminars in Arthritis and Rheumatism, 49(3), 351-357.
Scopus11 WoS6 Europe PMC62019 Hoon, E., Ruediger, C., Gill, T., Black, R., & Hill, C. (2019). A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis. Open Access Rheumatology : Research and Reviews, 11, 189-198.
Scopus10 WoS5 Europe PMC62019 Flurey, C. A., Tugwell, P. S., Black, R. J., Halls, S., Page, M. J., Robson, J. C., . . . Richards, B. (2019). The OMERACT Emerging Leaders Program: The Good, the Bad, and the Future. JOURNAL OF RHEUMATOLOGY, 46(8), 1047-1052.
Scopus6 WoS2 Europe PMC32017 Black, R. J., Robson, J. C., Goodman, S. M., Hoon, E., Lai, L. Y. H., Simon, L. S., . . . Hill, C. L. (2017). A patient-reported outcome measure for effect of glucocorticoid therapy in adults with inflammatory diseases is needed: report from the OMERACT 2016 special interest group. Journal of Rheumatology, 44(11), 1754-1758.
Scopus20 WoS15 Europe PMC142017 Mackie, S. L., Twohig, H., Neill, L. M., Harrison, E., Shea, B., Black, R. J., . . . Hill, C. L. (2017). The OMERACT core domain set for outcome measures for clinical trials in polymyalgia rheumatica. Journal of Rheumatology, 44(10), 1515-1521.
Scopus36 WoS26 Europe PMC252017 Black, R. J., Goodman, S. M., Ruediger, C., Lester, S., Mackie, S. L., & Hill, C. L. (2017). A survey of glucocorticoid adverse effects and benefits in rheumatic diseases: The patient perspective. Journal of Clinical Rheumatology, 23(8), 416-420.
Scopus24 WoS19 Europe PMC152017 Black, R., Lester, S., Buchbinder, R., Barrett, C., Lassere, M., March, L., . . . Hill, C. (2017). Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry. Arthritis Research and Therapy, 19(1), 253-1-253-8.
Scopus36 WoS27 Europe PMC222016 Lester, S., Hewitt, A., Ruediger, C., Bradbury, L., De Smit, E., Wiese, M., . . . Hill, C. (2016). PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis. RMD Open, 2(1), e000246-1-e000246-3.
Scopus8 WoS10 Europe PMC52016 Hill, C. L., Black, R. J., Nossent, J. C., Ruediger, C., Nguyen, L., Ninan, J. V., & Lester, S. (2016). Risk of mortality in patients with giant cell arteritis: a systematic review and meta-analysis. Seminars in Arthritis and Rheumatism, 46(4), 513-519.
Scopus64 WoS52 Europe PMC362016 Black, R. J., Hill, C. L., Lester, S., & Dixon, W. G. (2016). The association between systemic glucocorticoid use and the risk of cataract and glaucoma in patients with rheumatoid arthritis: a systematic review and meta- analysis. PLoS ONE, 11(11), e0166468.
Scopus40 WoS26 Europe PMC252015 Black, R., Joseph, R., Brown, B., Movahedi, M., Lunt, M., & Dixon, W. (2015). Half of UK patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: A retrospective drug utilisation study. Arthritis Research and Therapy, 17(1), 375.
Scopus27 WoS24 Europe PMC202014 Black, R. J., Spargo, L., Schultz, C., Chatterton, B., Cleland, L., Lester, S., . . . Proudman, S. M. (2014). Decline in hand bone mineral density indicates increased risk of erosive change in early rheumatoid arthritis. Arthritis Care & Research, 66(4), 515-522.
Scopus14 WoS14 Europe PMC92014 Dunstan, E., Lester, S., Rischmueller, M., Dodd, T., Black, R., Ahern, M., . . . Hill, C. (2014). Epidemiology of biopsy-proven giant cell arteritis in South Australia. Internal Medicine Journal, 44(1), 32-39.
Scopus58 WoS46 Europe PMC432013 Black, R., Roach, D., Rischmueller, M., Lester, S., & Hill, C. (2013). The use of temporal artery ultrasound in the diagnosis of giant cell arteritis in routine practice. International Journal of Rheumatic Diseases, 16(3), 352-357.
Scopus17 WoS14 Europe PMC122013 Dunstan, E., Lester, S., Black, R., Rischmueller, M., Chan, H., Hewitt, A., & Hill, C. (2013). No association between FCγR3B copy number variation and susceptibility to biopsy-proven giant cell arteritis. Arthritis, 2013, 514914-1-514914-4.
WoS1 Europe PMC12012 Black, R., Lester, S., Dunstan, E., Shahram, F., Nadji, A., Bayat, N., . . . Davatchi, F. (2012). Fc-gamma receptor 3B copy number variation is not a risk factor for Behçet’s disease. International Journal of Rheumatology, 2012, 1-4.
Scopus5 WoS7 Europe PMC52011 Black, R., Limaye, V., & Cleland, L. (2011). Acute Monoarthritis: What should one do?. Medicine Today: the peer reviewed journal of clinical practice, 12(3), 49-55. -
Conference Papers
Year Citation 2023 Ninan, J., Ruediger, C., Dyer, K. A., Dodd, T., Black, R. J., Lyne, S., . . . Hill, C. L. (2023). Incidence of biopsy-proven giant cell arteritis (GCA) in South Australia 2014–2020. In Frontiers in Medicine Vol. 10 (pp. 5 pages). Switzerland: FRONTIERS MEDIA SA.
DOI Scopus12023 Bryant, M. J., Munt, R., Black, R. J., Reynolds, A., & Hill, C. L. (2023). Joining forces to understand what matters most: qualitative insights into the patient experience of outpatient rheumatology care. In Rheumatology Advances in Practice Vol. 7 (pp. 10 pages). England: OXFORD UNIV PRESS.
DOI Scopus6 Europe PMC32022 Khoo, T., Lester, S., Hill, C., Whittle, S., Black, R., Tieu, J., & Rischmueller, M. (2022). CONNECTIVE TISSUE DISEASE RELATED INTERSTITIAL LUNG DISEASE IN A RHEUMATOLOGY CLINIC POPULATION. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 35). WILEY. 2022 Russell, O., Lester, S., Black, R., Lassere, M., Barrett, C., March, L., . . . Hill, C. (2022). EFFECT OF SOCIOECONOMIC STATUS (SES) ON OPIOID AND GLUCOCORTICOID USE IN AUSTRALIAN RHEUMATOID ARTHRITIS (RA) PATIENTS: A MEDICINE DISPENSING ANALYSIS USING DATA FROM THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD). In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 39-40). WILEY. 2022 Lynch, T., Sinnathurai, P., Buchbinder, R., Hill, C., Russell, O., Lester, S., . . . March, L. (2022). PREDICTORS OF DISCORDANT PRESCRIPTION MEDICATION SELF-REPORT IN THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD) COHORT. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 39). WILEY. 2022 Russell, O., Lester, S., Black, R., Lassere, M., Barrett, C., March, L., . . . Hill, C. (2022). THE EFFECT OF AREA-LEVEL SOCIOECONOMIC STATUS (SES) ON FUNCTIONAL STATUS IN AUSTRALIAN RHEUMATOID ARTHRITIS (RA) PATIENTS: DATA FROM THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD). In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 11). WILEY. 2021 Russell, O., Lester, S., Black, R., & Hill, C. (2021). SOCIOECONOMIC STATUS (SES) AND MEDICATION USE IN RHEUMATOID ARTHRITIS (RA): A SCOPING REVIEW. In ANNALS OF THE RHEUMATIC DISEASES Vol. 80 (pp. 1098-1099). ELECTR NETWORK: BMJ PUBLISHING GROUP.
DOI2021 Bridgewater, S., Dawson, J., Ndosi, M., Black, R. J., Cheah, T. L., Dures, E., . . . Robson, J. (2021). DEVELOPMENT OF A CONCEPTUAL FRAMEWORK FOR A PATIENT REPORTED OUTCOME MEASURE TO CAPTURE PATIENTS' PERCEPTIONS OF GLUCOCORTICOID THERAPY DURING TREATMENT FOR RHEUMATIC DISEASES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 80 (pp. 1441). Virtual Congress: BMJ PUBLISHING GROUP.
DOI WoS32021 He, J., Sunny, L., Sallis, O., McWilliams, L., Spargo, L., Metcalf, R., . . . Proudman, S. (2021). PULMONARY FUNCTION ABNORMALITIES IN RHEUMATOID ARTHRITIS, TO SCREEN OR NOT TO SCREEN?. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 39). WILEY. 2021 Black, R., Lester, S., Tieu, J., Sinnathurai, P., Barrett, C., Buchbinder, R., . . . Hill, C. L. (2021). MORTALITY ASSOCIATED WITH RHEUMATOID ARTHRITIS IN AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE PARTICIPANTS. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 37-38). WILEY. 2021 Lyon, A., Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Marine, F., . . . Hill, C. (2021). VACCINATION RATES, PERCEPTIONS AND INFORMATION SOURCES UTILISED BY AUSTRALIAN PATIENTS WITH INFLAMMATORY ARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 15). WILEY. 2020 Russell, O., Lester, M. S., Black, R., & Hill, C. (2020). SOCIOECONOMIC STATUS (SES) AND MEDICATION USE IN RHEUMATOID ARTHRITIS (RA): A SCOPING REVIEW. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 23). WILEY. 2020 Black, R., Lester, S., Hill, C., & Dixon, W. (2020). ORAL GLUCOCORTICOID USE AND THE DEVELOPMENT OF CATARACTS AND GLAUCOMA IN PATIENTS WITH INCIDENT RHEUMATOID ARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 46-47). WILEY. 2018 Fletcher, A., Lassere, M., Black, R., Barrett, C., Carroll, G., Lester, S., . . . Hill, C. (2018). Socioeconomic Differences in Opioid Use By People with Inflammatory Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 1 page). IL, Chicago: WILEY. 2015 Black, R. J., Joseph, R. M., Movahedi, M., Lunt, M., & Dixon, W. G. (2015). PRESCRIBER INFLUENCE ON ORAL GLUCOCORTICOID PRESCRIBING IN UK PRIMARY CARE FOR PATIENTS WITH RHEUMATOID ARTHRITIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 1291). BMJ PUBLISHING GROUP.
DOI2015 Black, R. J., Joseph, R. M., Movahedi, M., Lunt, M., & Dixon, W. G. (2015). Oral Glucocorticoid Prescribing Patterns in UK Primary Care for Patients with Rheumatoid Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 67 (pp. 2 pages). CA, San Francisco: WILEY. -
Conference Items
Year Citation 2022 Bridgewater, S., Shepherd, M. A., Dawson, J., Richards, P., Silverthorne, C., Ndosi, M., . . . Robson, J. (2022). PATIENT PERCEPTIONS OF IMPACT OF GLUCOCORTICOID THERAPY IN THE RHEUMATIC DISEASES: INTERNATIONAL DEVELOPMENT OF A TREATMENT-SPECIFIC PATIENT REPORTED OUTCOME MEASURE. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. DENMARK, Copenhagen: BMJ PUBLISHING GROUP.
DOI2021 Rischin, A., Liew, D., Black, R., Fletcher, A., Buchbinder, R., Lassere, M., . . . Hill, C. (2021). HEALTHCARE ACCESS AND ATTITUDES TOWARDS TELEHEALTH DURING THE EARLY PHASE OF THE COVID-19 PANDEMIC AMONG AN AUSTRALIAN COHORT WITH INFLAMMATORY ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2021 Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Rowett, D., Black, R., . . . Hill, C. (2021). ATTITUDES OF AUSTRALIANS WITH INFLAMMATORY ARTHRITIS TO BIOLOGIC THERAPY AND BIOSIMILARS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2020 Venter, G., Tieu, J., Black, R., Lester, S., Leonardo, N., Whittle, S. L., . . . Hill, C. L. (2020). PERSPECTIVES OF GLUCOCORTICOID USE IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2020 Black, R., Lester, S., Ninan, J., Ruediger, C., & Hill, C. (2020). INCIDENCE AND PREVALENCE OF GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA RECORDED IN AUSTRALIAN PRIMARY CARE ELECTRONIC MEDICAL RECORDS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2019 Black, R., Lester, S., Hill, C., & Dixon, W. (2019). THE IMPACT OF ORAL GLUCOCORTICOIDS ON THE DEVELOPMENT OF CATARACTS AND GLAUCOMA IN INCIDENT RHEUMATOID ARTHRITIS PATIENTS. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Madrid, SPAIN: BMJ PUBLISHING GROUP.
DOI2018 Cheah, J., Robson, J., Black, R., Goodman, S. M., Lester, S., Mackie, S., & Hill, C. (2018). The Patient's Perspective of Glucocorticoid Use: A Systematic Literature Review of Quantitative and Qualitative Studies. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. IL, Chicago: WILEY. 2016 Black, R., Goodman, S. M., Ruediger, C., Lester, S., Mackie, S., & Hill, C. (2016). Glucocorticoid Adverse Effects - the Patient Perspective. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. DC, Washington: WILEY. 2015 Hill, C., Black, R., Nossent, J., Ruediger, C., Ninan, J., & Lester, S. (2015). Risk of mortality in patients with giant cell arteritis: a systematic review and meta-analysis. Poster session presented at the meeting of Abstracts of the 2015 ACR/ARHP Annual Meeting, as published in Arthritis & Rheumatology. San Francisco, CA: Wiley-Blackwell.
DOI WoS1
Primary Investigator Grants
1. Arthritis Australia- Australian Rheumatology Association Project Grant
Title: A Randomised Clinical Trial of a Glucocorticoid Tapering Intervention for Rheumatoid Arthritis Patients
Amount: $43,000
Period of award: 2023
Co-Investigator Grants
1. The Hospital Research Foundation Group- Advancing Diagnosis or Treatment of Child and Adolescent Rheumatic Diseases grant round
Title: Optimising transition care for adolescents with juvenile rheumatic disease in South Australia
Amount: $125,000
Period of Award: 2023-2025
PI: Prof Catherine Hill
2. Arthritis Australia 2021-2022 National Research Program- Australian Rheumatology Association Grant-In-Aid
Title: Validation and integration of Patient Reported Experience Measures in outpatient rheumatology care in Australia
Amount: $15,000
Period of Award: 2022
PI: Dr Madeline Bryant
3. Arthritis Australia National Research Program 2020- Australian Rheumatology Association Project Grant
Title: Development of a patient reported outcome measure (prom) for glucocorticoid impact in rheumatic diseases
Amount: $15,000
Period of Award: 2021
PI: Prof Catherine Hill
Other Funding
ARA Early Career Excellence Award 2024 Amount: $2,000
RACP Barbara Cameron ARA Research Establishment Fellowship 2020 Amount: $50,000
Arthritis SA/ARA SA Branch Postgraduate Scholarship 2015 Amount: $20,000
Australian Postgraduate Award, The University of Adelaide (for PhD) 2014 Amount: $25,392 per year
Arthritis Australia Ken Muirden Overseas Training Fellowship 2013 Amount: $100,000
-
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2023 Co-Supervisor The influence of socioeconomic factors on medication use and health outcomes in Australians with rheumatoid arthritis Doctor of Philosophy Doctorate Full Time Dr Oscar Kenneth Russell 2023 Co-Supervisor Patient Reported Experience Measures in Australian outpatient rheumatology care Doctor of Philosophy Doctorate Full Time Dr Madeleine Bryant
Connect With Me
External Profiles
